Published in Women's Health Weekly, August 24th, 2006
Study 1: Breast magnetic resonance imaging screening for BRCA1/2 carriers may be cost-effective.
"Women with inherited BRCA1/2 mutations are at high risk for breast cancer, which mammography often misses. Screening with contrast-enhanced breast magnetic resonance imaging (MRI) detects cancer earlier but increases costs and results in more false-positive scans," according to investigators writing in the Journal of the American Medical Association.
S.K. Plevritis and colleagues of Stanford University sought "to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.